Chapter 9 Inhibitory effects of ibogaine on cocaine self-administration in rats

Abstract - In order to determine the potential anti-addictive properties of ibogaine, we used the cocaine self-administration model in rats. The results indicate that a single injection of ibogaine (40 mg/kg i.p.) produced a significant decrease of cocaine intake, which remained unaltered for more than 48 h. Since the half-life time of ibogaine is short, this might suggest the involvement of one or several active metabolites of ibogaine in cocaine intake. Repetitive administration of ibogaine on three consecutive days also induced a pronounced decrease of cocaine intake. However, a more prominent inhibitory effect on cocaine intake was observed in animals treated repeatedly with ibogaine (40 mg/kg i.p.), once each week for 3 consecutive weeks. These results indicate that ibogaine or its metabolite(s) is a long-lasting interruptor of cocaine dependence, which supports similar observations from uncontrolled clinical studies. Published in European Journal of Pharmacology 241: 261-265, 1993.

Ibogaine, an indole alkaloid found in the root bark of the African shrub Tabernanthe iboga, has been used in Gabon (West Central Africa) in low doses as a stimulant (combat fatigue, hunger and thirst) and in high doses for its hallucinogenic properties (religious rituals).

Recent animal studies and non-controlled observations in humans indicate that ibogaine may significantly affect drug dependence phenomena such as drug withdrawal and intake of addictive drugs. Accordingly, it has been demonstrated that ibogaine (i.c.v.) attenuated many (but not all) symptoms of naloxone-precipitated withdrawal in morphine-dependent rats (Dzoljic et al., 1988). A similar anti-withdrawal effect of ibogaine has been observed in morphine-dependent monkeys (Aceto et al., 1989) and rats (Glick et al., 1992).

Related to the intake of addictive drugs, it has been shown that ibogaine pretreatment decreases intravenous morphine self-administration in rats for several days (Glick et al., 1991). These results of animal experiments are in accordance with the long-lasting interruption of heroin abuse by ibogaine in humans (Lotsof, 1985). Ibogaine is also claimed to interrupt cocaine and amphetamine abuse and it was suggested that series of four treatments may be effective for several years (Lotsof, 1986). Other claims are that ibogaine attenuates alcohol and nicotine/tobacco dependency syndromes (Lotsof, 1989, 1991).

Materials and methods

Animals
Male wistar rats. (TNO Zeist) were used, weighing 200-250 g at the start of the experiments. The animals were housed in groups with water and food ad libitum. Artificial light was supplied on a 12-h light/dark cycle.

Operation procedure

All animals were anaesthetized with sodium pentobarbital (60 mg/kg i.p.) and surgically implanted with a chronic i.v. jugular catheter (0.5 mm inside diameter, 1.0 mm outside diameter, polyethylene tubing). The catheter was passed subcutaneously to a small incision at the back of the neck. After the operation the animals were housed individually with food and water ad libitum. Two days before the start of the experiments (i.e. 5-6 days after operation), the animals were brought to the test room and were deprived of food in order to obtain a weight reduction of about 20%. Weight reduction was introduced in order to facilitate acquisition of self-administration (Takahashi et al., 1978). A reversed 12-h light/dark cycle (lights out 8.00 - 20.00 h) was maintained during the whole experiment.

Apparatus

The experiments were performed in operant conditioning chambers. Cocaine infusions (1.2 mg/kg), consisting of 0.25 ml fluid (pH 7.30-7.35) delivered in 20 s, occurred when the reinforcement lever was depressed. During the infusion, the stimulus light was turned off and pressing the same lever had no programmed consequences.

Test-procedure

Following 5-6 days of postoperative recovery, the rats were connected to an infusion pump (Braun Perfusor Secura MRD) by polyethylene tubing and a fluid swivel, which permitted unlimited movement of the animal during the session. Session length was 3 h each day (during the dark period of the cycle), 5 days per week with 2 days of no testing (during weekends, between each 5-day block of testing). The study of the effect of ibogaine began when the baseline rate of cocaine self-administration stabilized (< 10% variation between 3 consecutive sessions) after 12-16 days (sessions). These animals were randomly divided into vehicle and ibogaine-treated groups. The experiments lasted about 6 weeks (including the first 2 weeks used for stabilization of cocaine intake).

Experimental groups

Vehicle (1.0 ml/kg i.p.) or ibogaine was given 30 min prior to self-administration testing and the behaviour of animals was monitored for the subsequent 3 h.

Repetitive administration of ibogaine (40 mglkg i.p.). In one group of animals (n=5) ibogaine was administered once on each of 3 consecutive days, while the other group (n=5) received ibogaine once at the beginning of each of 3 consecutive weeks.

Drugs

Cocaine hydrochloride (OPG, Utrecht, Netherlands) was dissolved in saline and the pH was adjusted to 7.30-7.35. Ibogaine hydrochloride (kindly donated by H. Lotsof, NDA, New York) was dissolved in distilled water.

Data analysis

Responses were summed over the 3-h test period and subjected to two-way analysis of variance (ANOVA) with repeated measurements on days. Individual comparisons of means were made with Student's t-test (between baseline and treated groups and between vehicle and ibogaine-treated groups) with significance at P<0.05 level.

Results

Single administration of ibogaine (10-40 mg/kg i.p. n= 6-7 per dose)

Behaviour. Administration of ibogaine in cocaine-dependent rats induced within 4 min stiffness of the hind legs, tremor, ataxia and hypersensitivity (jumping or , violent locomotion when touched). The severity of this behavioral syndrome was dose dependent and, in the case of the highest dose of ibogaine (40 mg/kg), the effect lasted for a maximum of 30 min. Thereafter, animals showed normal behaviour and were used for the self-administration procedure.

Cocaine intake. The baseline cocaine intake was 5.0 ± 0.5 mg/kg (Fig. 1). A single injection of 40 mg/kg ibogaine produced a significant depression of cocaine intake, while 10 and 20 mg/kg were ineffective (Fig. 1). The inhibitory effect of a single administration of ibogaine on cocaine intake became more prominent on the next day and remained below the control level for the 24 h following (48 h after drug administration, Fig. 1). Further studies were performed with the 40 mg/kg dose of ibogaine.

Repeated (three) administration of ibogaine (40 mglkg i.p.)

Ibogaine administered on each of 3 consecutive days. Compared to the baseline (5.3 ± 0.4), administration of vehicle (1.0 ml/kg i.p. n=5) on each of 3 consecutive days did not induce significant changes in cocaine intake (Fig. 2). However, a significant decrease of the cocaine intake (n=5) occurred on the second day of ibogaine treatment. After the third injection of ibogaine, the inhibitory effect on cocaine intake lasted for the next 24 h (Fig. 2). This effect on cocaine intake was not significantly different from that of a single injection of ibogaine, but was shorter (24h versus 48h)

Fig. 1. Effect of a single dose of ibogaine (1040 mg/kg i.p. n= 6-7 per dose) on cocaine intake in rats. The baseline cocaine intake (0 5.0±0.5 mg/kg) was calculated as the average rate of three consecutive sessions (<10% variation) preceding treatment with vehicle (distilled water 1.0 ml/kg i.p. n=7) or ibogaine. Vehicle (T) or ibogaine (T) were administered 30 min before the session started. The data are expressed as means of cocaine intake per session. * Indicates a significant decrease of cocaine intake (ANOVA and t-test P<0.05) compared to baseline intake and vehicle-treated group. Note that a single injection of ibogaine (40 mg/kg) exerted a long-lasting (48 h) inhibition of cocaine intake.             Fig.2. Effect of repeated administration of ibogaine (40 mg/kg i.p. n=5, given once on each of three consecutive sessions) on cocaine intake in rats. The baseline cocaine intake (E 5.3±0.4 mg/kg) was calculated as the average rate of three consecutive sessions (<10% variation) preceding treatment with vehicle (distilled water 1.0 ml/kg i.p. n=5) or ibogaine. Vehicle (T) or ibogaine (T) was administered 30 min before the session started. The data are expressed as means ± SEM cocaine intake per session. Indicates a significant decrease of cocaine intake (ANOVA and t-test P<0.05) compared to baseline intake and vehicle-treated group. Note that each injection of ibogaine significantly decreased cocaine intake.